Annual Total Debt:
$2.59B-$157.38M(-5.72%)Summary
- As of today (May 29, 2025), AMRX annual total debt is $2.59 billion, with the most recent change of -$157.38 million (-5.72%) on December 31, 2024.
- During the last 3 years, AMRX annual total debt has fallen by -$282.92 million (-9.84%).
- AMRX annual total debt is now -11.95% below its all-time high of $2.94 billion, reached on December 31, 2020.
Performance
AMRX Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$2.58B-$13.64M(-0.53%)Summary
- As of today (May 29, 2025), AMRX quarterly total debt is $2.58 billion, with the most recent change of -$13.64 million (-0.53%) on March 31, 2025.
- Over the past year, AMRX quarterly total debt has dropped by -$166.33 million (-6.06%).
- AMRX quarterly total debt is now -21.34% below its all-time high of $3.28 billion, reached on March 31, 2020.
Performance
AMRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
AMRX Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.7% | -6.1% |
3 y3 years | -9.8% | -10.0% |
5 y5 years | -6.4% | -21.3% |
AMRX Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -9.8% | at low | -11.0% | at low |
5 y | 5-year | -11.9% | at low | -21.3% | at low |
alltime | all time | -11.9% | >+9999.0% | -21.3% | >+9999.0% |
AMRX Total debt History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $2.58B(-0.5%) |
Dec 2024 | $2.59B(-5.7%) | $2.59B(-1.9%) |
Sep 2024 | - | $2.64B(-3.0%) |
Jun 2024 | - | $2.73B(-0.8%) |
Mar 2024 | - | $2.75B(-0.2%) |
Dec 2023 | $2.75B(-3.3%) | $2.75B(-1.9%) |
Sep 2023 | - | $2.80B(-1.9%) |
Jun 2023 | - | $2.86B(+0.2%) |
Mar 2023 | - | $2.85B(+0.3%) |
Dec 2022 | $2.85B(-1.1%) | $2.85B(-0.4%) |
Sep 2022 | - | $2.86B(-1.4%) |
Jun 2022 | - | $2.90B(+1.1%) |
Mar 2022 | - | $2.87B(-0.3%) |
Dec 2021 | $2.88B | $2.88B(-0.3%) |
Sep 2021 | - | $2.88B(-1.2%) |
Jun 2021 | - | $2.92B(-0.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $2.92B(-0.8%) |
Dec 2020 | $2.94B(+6.3%) | $2.94B(-0.6%) |
Sep 2020 | - | $2.96B(-0.4%) |
Jun 2020 | - | $2.97B(-9.3%) |
Mar 2020 | - | $3.28B(+18.4%) |
Dec 2019 | $2.77B(+2.9%) | $2.77B(-0.1%) |
Sep 2019 | - | $2.77B(-0.3%) |
Jun 2019 | - | $2.78B(-0.3%) |
Mar 2019 | - | $2.79B(+3.7%) |
Dec 2018 | $2.69B(+81.3%) | $2.69B(-6.4%) |
Sep 2018 | - | $2.87B(+3.4%) |
Jun 2018 | - | $2.78B(>+9900.0%) |
Mar 2018 | - | $0.00(-100.0%) |
Dec 2017 | $1.48B(>+9900.0%) | $1.48B(>+9900.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00 |
Dec 2016 | $0.00 | - |
FAQ
- What is Amneal Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual total debt year-on-year change?
- What is Amneal Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly total debt year-on-year change?
What is Amneal Pharmaceuticals annual total debt?
The current annual total debt of AMRX is $2.59B
What is the all time high annual total debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual total debt is $2.94B
What is Amneal Pharmaceuticals annual total debt year-on-year change?
Over the past year, AMRX annual total debt has changed by -$157.38M (-5.72%)
What is Amneal Pharmaceuticals quarterly total debt?
The current quarterly total debt of AMRX is $2.58B
What is the all time high quarterly total debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly total debt is $3.28B
What is Amneal Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, AMRX quarterly total debt has changed by -$166.33M (-6.06%)